Christine Allen

Dr. Christine Allen is CEO and co-founder of Intrepid Labs Inc., a company leveraging
AI, automation, and deep pharmaceutical expertise to accelerate drug formulation and
develop proprietary delivery technologies. Intrepid’s approach helps bring
transformative medicines to patients faster, improving therapeutic outcomes and
enhancing patient care.

Christine is also a full professor at the University of Toronto (U of T), internationally
recognized for her contributions to drug formulation and development, with over 180
peer-reviewed publications. She is a distinguished fellow of both the American Institute
for Medical and Biological Engineering and the Canadian Academy of Health Sciences.
Christine has held significant leadership roles, including President of both the Controlled
Release Society and the Canadian Society for Pharmaceutical Sciences, and
Editor-in-Chief of the Journal of Controlled Release.

Her academic leadership includes serving as the inaugural Associate Vice-President
and Vice Provost Strategic Initiatives and Interim Dean of the Leslie Dan Faculty of
Pharmacy at U of T.